Related Experiment Videos
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study
European Journal of Cancer (Oxford, England : 1990)
|May 8, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Breast (Edinburgh, Scotland)·2022
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Immediate breast reconstruction with latissimus dorsi flap for patients with local recurrence of breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody-drug conjugates: A literature review.
European journal of cancer (Oxford, England : 1990)·2026
Safety and tolerability of anselamimab in participants with light chain amyloidosis: Results from a phase 2 study.
European journal of cancer (Oxford, England : 1990)·2026
Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial.
European journal of cancer (Oxford, England : 1990)·2026
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study.
European journal of cancer (Oxford, England : 1990)·2026
Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative.
European journal of cancer (Oxford, England : 1990)·2026
Oxygen-Gradient-Responsive Photosensitizing Gadolinium Phthalocyaninate for Self-Adaptive Type II/I Photodynamic Therapy Toward Heterogeneous Tumor Suppression.
Small (Weinheim an der Bergstrasse, Germany)·2026
An Immunogenic Cell Death-Enhanced Self-Assembled Nanoparticle-Composite Hydrogel for Postoperative Local Immunotherapy of Melanoma.
Omics : a journal of integrative biology·2026